Rate of reinfections after SARS-CoV-2 primary infection in the population of an Italian province: a cohort study

被引:19
作者
Flacco, M. E. [1 ]
Martellucci, C. Acuti [1 ]
Soldato, G. [2 ]
Carota, R. [3 ]
Fazii, P. [4 ]
Caponetti, A. [5 ]
Manzoli, L. [1 ]
机构
[1] Univ Ferrara, Dept Med Sci, I-44121 Ferrara, Italy
[2] Local Hlth Unit Pescara, Dept Prevent Med, Publ Hlth Sect, I-65100 Pescara, Italy
[3] Local Hlth Unit Pescara, Div Legal Affairs, Publ Hlth Data Ctr, I-65100 Pescara, Italy
[4] Osped Pescara, Microbiol Unit, Local Hlth Unit Pescara, I-65100 Pescara, Italy
[5] Hosp Directorate, Local Hlth Unit Pescara, I-65100 Pescara, Italy
关键词
COVID-19; Italy; reinfection; relapse; SARS-CoV-2;
D O I
10.1093/pubmed/fdab346
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background Current data suggest that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) reinfections are rare, but no information are available on minors and after 12 months of follow-up. Methods This retrospective cohort study included all the population of an Italian Province, diagnosed with a SARS-CoV-2 infection from March 2020 to May 2021. The primary outcome was the incidence of a reinfection, defined as a new positive polymerase chain reaction (PCR) test occurring >= 90 days after complete resolution of the first infection, and data were retrieved from the official datasets (coronavirus disease 2019 [COVID-19], demographic, hospital and co-pay exemption) of the Local Health Unit (LHU) of Pescara. Results After an average of 201 days of follow-up (max. 414), we recorded 24 reinfections >= 90 days after the resolution of the first 7173 infections (0.33%). Four reinfections required hospitalization, one was lethal. Most of the reinfections (n = 13) occurred 6-9 months after the resolution of the first infection; no new infection was detected 12 or more months later and among the 832 minors. Conclusions This study confirms previous findings on a low risk of SARS-CoV-2 reinfection. If confirmed, these findings suggest that more targeted restriction policies can be applied to the subjects that recovered after a first infection.
引用
收藏
页码:E475 / E478
页数:4
相关论文
共 13 条
[1]   SARS-CoV-2 antibody-positivity protects against reinfection for at least seven months with 95% efficacy [J].
Abu-Raddad, Laith J. ;
Chemaitelly, Hiam ;
Coyle, Peter ;
Malek, Joel A. ;
Ahmed, Ayeda A. ;
Mohamoud, Yasmin A. ;
Younuskunju, Shameem ;
Ayoub, Houssein H. ;
Al Kanaani, Zaina ;
Al Kuwari, Einas ;
Butt, Adeel A. ;
Jeremijenko, Andrew ;
Kaleeckal, Anvar Hassan ;
Latif, Ali Nizar ;
Shaik, Riyazuddin Mohammad ;
Rahim, Hanan F. Abdul ;
Nasrallah, Gheyath K. ;
Yassine, Hadi M. ;
Al Kuwari, Mohamed Ghaith ;
Al Romaihi, Hamad Eid ;
Al-Thani, Mohamed H. ;
Al Khal, Abdullatif ;
Bertollini, Roberto .
ECLINICALMEDICINE, 2021, 35
[2]   How the Italian NHS Is Fighting Against the COVID-19 Emergency [J].
Boccia, Stefania ;
Cascini, Fidelia ;
McKee, Martin ;
Ricciardi, Walter .
FRONTIERS IN PUBLIC HEALTH, 2020, 8
[3]  
ECDC, 2019, European Centre for Disease Prevention and Control - ECDC strategic framework for the integration of molecular and genomic typing into European surveillance and multi-country outbreak investigations-2019-2021
[4]   Interim Estimates of COVID-19 Vaccine Effectiveness in a Mass Vaccination Setting: Data from an Italian Province [J].
Flacco, Maria Elena ;
Soldato, Graziella ;
Martellucci, Cecilia Acuti ;
Carota, Roberto ;
Di Luzio, Rossano ;
Caponetti, Antonio ;
Manzoli, Lamberto .
VACCINES, 2021, 9 (06)
[5]   Spread and dynamics of the COVID-19 epidemic in Italy: Effects of emergency containment measures [J].
Gatto, Marino ;
Bertuzzo, Enrico ;
Mari, Lorenzo ;
Miccoli, Stefano ;
Carraro, Luca ;
Casagrandi, Renato ;
Rinaldo, Andrea .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2020, 117 (19) :10484-10491
[6]   SARS-CoV-2 infection rates of antibody-positive compared with antibody-negative health-care workers in England: a large, multicentre, prospective cohort study (SIREN) [J].
Hall, Victoria Jane ;
Foulkes, Sarah ;
Charlett, Andre ;
Atti, Ana ;
Monk, Edward J. M. ;
Simmons, Ruth ;
Wellington, Edgar ;
Cole, Michelle J. ;
Saei, Ayoub ;
Oguti, Blanche ;
Munro, Katie ;
Wallace, Sarah ;
Kirwan, Peter D. ;
Shrotri, Madhumita ;
Vusirikala, Amoolya ;
Rokadiya, Sakib ;
Kall, Meaghan ;
Zambon, Maria ;
Ramsay, Mary ;
Brooks, Tim ;
Brown, Colin S. ;
Chand, Meera A. ;
Hopkins, Susan .
LANCET, 2021, 397 (10283) :1459-1469
[7]   Assessment of protection against reinfection with SARS-CoV-2 among 4 million PCR-tested individuals in Denmark in 2020: a population-level observational study [J].
Hansen, Christian Holm ;
Michlmayr, Daniela ;
Gubbels, Sophie Madeleine ;
Molbak, Kare ;
Ethelberg, Steen .
LANCET, 2021, 397 (10280) :1204-1212
[8]   Association of SARS-CoV-2 Seropositive Antibody Test With Risk of Future Infection [J].
Harvey, Raymond A. ;
Rassen, Jeremy A. ;
Kabelac, Carly A. ;
Turenne, Wendy ;
Leonard, Sandy ;
Klesh, Reyna ;
Meyer, William A., III ;
Kaufman, Harvey W. ;
Anderson, Steve ;
Cohen, Oren ;
Petkov, Valentina I. ;
Cronin, Kathy A. ;
Van Dyke, Alison L. ;
Lowy, Douglas R. ;
Sharpless, Norman E. ;
Penberthy, Lynne T. .
JAMA INTERNAL MEDICINE, 2021, 181 (05) :672-679
[9]  
Health Policy Watch, 2021, PEOPL WHO HAV HAD CO
[10]  
Italian Ministry of Health, 2021, EU DIG COVID CERT